SPARC partners with UCSF and Tiller Therapeutics to license oncology asset
Agreement grants SPARC equity in Tiller for development and commercialisation of joint oncology intellectual property
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Anil Raghavan
SPARC enters into licensing deal with CMS to develop and commercialise products
The initial term of the agreement shall be 20 years from the date of first commercial sale of each product in the territory and…